Godavari Drugs (BOM:530317) E10: ₹5.12 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530317 Godavari Drugs Ltd BOM:530317
54 GF Score
Price ₹102.50
GF Value ₹72.35
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Godavari Drugs E10?

Godavari Drugs BOM:530317 -0.49% 54 E10 is ₹5.12 as of Mar. 2026. GuruFocus rates BOM:530317 with a GF Score™ of 54/100 and a GF Value™ of ₹72.35 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Godavari Drugs's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹1.640. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹5.12 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Godavari Drugs's average E10 Growth Rate was 9.60% per year. During the past 3 years, the average E10 Growth Rate was 7.10% per year. During the past 5 years, the average E10 Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Godavari Drugs was 23.60% per year. The lowest was 7.10% per year. And the median was 9.50% per year.

As of today (2026-08-12), Godavari Drugs's current stock price is ₹102.50. Godavari Drugs's E10 for the quarter that ended in Mar. 2026 was ₹5.12. Godavari Drugs's Shiller PE Ratio of today is 20.02.

During the past 13 years, the highest Shiller PE Ratio of Godavari Drugs was 28.39. The lowest was 14.57. And the median was 20.37.


Godavari Drugs  (BOM:530317) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Godavari Drugs's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=102.50/5.12
=20.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Godavari Drugs was 28.39. The lowest was 14.57. And the median was 20.37.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Godavari Drugs E10 Related Terms


Godavari Drugs E10 Historical Data

* Premium members only.

The historical data trend for Godavari Drugs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Godavari Drugs E10 Chart

Godavari Drugs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.56 4.17 4.74 4.67 5.12

Godavari Drugs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.67 4.75 4.90 4.98 5.12

BOM:530317 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Godavari Drugs Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's Shiller PE Ratio falls into.


BOM:530317
54GF Score
Godavari Drugs Ltd BOM:530317
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Godavari Drugs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Godavari Drugs's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.64/164.2724*164.2724
=1.640

Current CPI (Mar. 2026) = 164.2724.

Godavari Drugs Quarterly Data

per share eps CPI Adj_EPS
201606 0.580 105.961 0.899
201609 0.530 105.961 0.822
201612 0.500 105.196 0.781
201703 0.750 105.196 1.171
201706 0.120 107.109 0.184
201709 0.100 109.021 0.151
201712 0.440 109.404 0.661
201803 0.450 109.786 0.673
201806 0.230 111.317 0.339
201809 0.270 115.142 0.385
201812 0.360 115.142 0.514
201903 0.480 118.202 0.667
201906 0.570 120.880 0.775
201909 0.360 123.175 0.480
201912 0.720 126.235 0.937
202003 1.010 124.705 1.330
202006 1.130 127.000 1.462
202009 1.310 130.118 1.654
202012 1.330 130.889 1.669
202103 1.710 131.771 2.132
202106 1.890 134.084 2.316
202109 1.620 135.847 1.959
202112 1.770 138.161 2.105
202203 1.690 138.822 2.000
202206 1.220 142.347 1.408
202209 1.150 144.661 1.306
202212 0.890 145.763 1.003
202303 1.770 146.865 1.980
202306 1.080 150.280 1.181
202309 1.140 151.492 1.236
202312 1.620 152.924 1.740
202403 3.540 153.035 3.800
202406 2.170 155.789 2.288
202409 1.450 157.882 1.509
202412 1.020 158.323 1.058
202503 1.190 157.552 1.241
202506 1.380 159.755 1.419
202509 1.330 162.289 1.346
202512 1.010 163.281 1.016
202603 1.640 164.272 1.640

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹5.12 mean?
Godavari Drugs (BOM:530317) has a E10 of ₹5.12 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Godavari Drugs and its competitors.
Is Godavari Drugs' E10 too high?
Godavari Drugs' current E10 is ₹5.12. Overall, Godavari Drugs has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Godavari Drugs' E10 compare to ZTS?
Godavari Drugs' E10 of ₹5.12 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Godavari Drugs and its competitors. Godavari Drugs's current E10 is ₹5.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Godavari Drugs stock overvalued right now?
Based on GuruFocus' analysis, Godavari Drugs (BOM:530317) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹72.35, compared to a current price of ₹102.50 — trading 41.7% above its estimated fair value. The current E10 is ₹5.12. Godavari Drugs' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Godavari Drugs (BOM:530317), the current E10 is ₹5.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Godavari Drugs (BOM:530317) Overvalued in 2026?

Based on GuruFocus' analysis, Godavari Drugs stock appears to be overvalued. The current stock price of ₹102.50 is trading 41.7% above its estimated GF Value™ of ₹72.35. GuruFocus considers Godavari Drugs to be Significantly Overvalued.

Key valuation signals for BOM:530317:

  • E10: ₹5.12
  • GF Value™: ₹72.35 vs. price of ₹102.50 (41.7% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the BOM:530317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Godavari Drugs Business Description

Address Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing of APl's, intermediates and fine chemicals,. The firm's product includes Ciprofloxacin hydrochloride, ciprofloxacin, ciprofloxacin lactate, ciprofloxacin lactate, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.
54GF Score

Get the complete analysis for BOM:530317

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹102.50
Price
₹72.35
GF Value